𝛼SK or Searchbullish
Island Pharmaceuticals Ltd - Galidesivir manufacturing commenced for Ebola deployment
SUMMARY
- Island Pharmaceuticals Ltd (ASX:ILA) is an antiviral therapeutics company targeting infectious diseases.
- ILA has announced that GMP manufacture of Galidesivir active pharmaceutical ingredient (API) commenced on 1 October at PI Health Sciences (PIHS).
- The first 5kg GMP API batch should be available by the end of October and is to be used in ILA’s approved emergency-use programme in Uganda during the current Bundibugyo Ebola outbreak.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Island Pharmaceuticals Ltd - Galidesivir manufacturing commenced for Ebola deployment06 Oct 2026
x